Molecular biologist Olga Matveeva explains what is actually known about Russian therapeutic cancer vaccines, why they cannot be compared with conventional vaccinations, and why it is dangerous to “introduce” them without full clinical trials. We will discuss: how therapeutic vaccines differ from preventive ones; why cancer cannot be defeated with one “pill”; what is known about Russian developments; parallels with Sputnik and EpiVacCorona; why p…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
Molecular biologist Olga Matveeva explains what is actually known about Russian therapeutic cancer vaccines, why they cannot be compared with conventional vaccinations, and why it is dangerous to “introduce” them without full clinical trials. We will discuss: how therapeutic vaccines differ from preventive ones; why cancer cannot be defeated with one “pill”; what is known about Russian developments; parallels with Sputnik and EpiVacCorona; why p…